• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿根廷法布里病女性患者的主要器官受累情况。

Major Organic Involvement in Women with Fabry Disease in Argentina.

作者信息

Perretta Fernando, Antongiovanni Norberto, Jaurretche Sebastián

机构信息

Servicio de Terapia Intensiva del Hospital Dr. Enrique Erill de Escobar, Buenos Aires, Argentina.

GINEF (Grupo de Investigación Nefrológica en la Enfermedad de Fabry), Buenos Aires, Argentina.

出版信息

ScientificWorldJournal. 2018 May 21;2018:6515613. doi: 10.1155/2018/6515613. eCollection 2018.

DOI:10.1155/2018/6515613
PMID:29950951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5987241/
Abstract

Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from the deficiency or absence of the alpha galactosidase A enzyme. Organic involvement in men is well known, but in women it is controversial, partly due to the random X-chromosomes inactivation (Lyon hypothesis). The aim of this study was to describe the organic involvement in women at the time of FD diagnosis. A descriptive, cross-sectional and multicenter study was carried out. Thirty-five women with FD from three reference centers in Argentina were evaluated. The mean age of the whole group ( = 35) was 26.6 ± 16.9 years; 22 were adult (over 18) and 13 were paediatric patients. Enzymatic activity was performed in 29/35 patients, which was normal in 24/29 (82.8%). Seven different mutations of the GLA gene were found. The results showed urinary protein loss (45.7%) and decreased glomerular filtration rate (31.4%), mainly in adults. And also, cornea verticillata (56.5%), peripheral neuropathy (51.4%), cardiovascular manifestations (31.4%), hearing loss (20%), angiokeratomas (20%), central nervous system (17.1%), and gastrointestinal involvement (14.3%). Organic compromise in females with FD may be as severe as in men. This analysis has demonstrated a significant proportion of women with signs, symptoms, and major organic involvement at FD diagnosis.

摘要

法布里病(FD)是一种X连锁溶酶体贮积症,由α-半乳糖苷酶A酶缺乏或缺失引起。男性的器官受累情况众所周知,但女性的情况存在争议,部分原因是随机的X染色体失活(莱昂假说)。本研究的目的是描述FD诊断时女性的器官受累情况。开展了一项描述性、横断面多中心研究。对来自阿根廷三个参考中心的35名FD女性患者进行了评估。整个组(n = 35)的平均年龄为26.6±16.9岁;22名是成年人(18岁以上),13名是儿科患者。对29/35名患者进行了酶活性检测,其中24/29(82.8%)结果正常。发现了GLA基因的7种不同突变。结果显示主要在成年人中出现尿蛋白丢失(45.7%)和肾小球滤过率降低(31.4%)。此外,还有角膜涡状浑浊(56.5%)、周围神经病变(51.4%)、心血管表现(31.4%)、听力损失(20%)、血管角质瘤(20%)、中枢神经系统受累(17.1%)和胃肠道受累(14.3%)。FD女性患者的器官损害可能与男性一样严重。该分析表明,很大一部分女性在FD诊断时有体征、症状和主要器官受累情况。

相似文献

1
Major Organic Involvement in Women with Fabry Disease in Argentina.阿根廷法布里病女性患者的主要器官受累情况。
ScientificWorldJournal. 2018 May 21;2018:6515613. doi: 10.1155/2018/6515613. eCollection 2018.
2
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.法布里病女性患者常出现主要器官受累:来自法布里病注册研究的经验教训。
Mol Genet Metab. 2008 Feb;93(2):112-28. doi: 10.1016/j.ymgme.2007.09.013. Epub 2007 Nov 26.
3
Early Renal Involvement in a Girl with Classic Fabry Disease.经典型法布里病女童的早期肾脏受累情况
Case Rep Nephrol. 2017;2017:9543079. doi: 10.1155/2017/9543079. Epub 2017 Oct 1.
4
Fabry disease.法布里病
Skinmed. 2011 May-Jun;9(3):173-7.
5
[Evaluation of patients with Fabry disease in Argentina].[阿根廷法布里病患者的评估]
Medicina (B Aires). 2010;70(1):37-43.
6
Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.法布里病:GLA 基因的多态单体型和一种新的错义突变。
Clin Genet. 2012 Mar;81(3):224-33. doi: 10.1111/j.1399-0004.2011.01689.x. Epub 2011 May 25.
7
Fabry disease in Argentina: an evaluation of patients enrolled in the Fabry Registry.阿根廷的法布瑞病:法布瑞登记研究中登记患者的评估。
Int J Clin Pract. 2013 Jan;67(1):66-72. doi: 10.1111/ijcp.12081.
8
Diagnosing lysosomal storage disorders: Fabry disease.溶酶体贮积症的诊断:法布里病
Curr Protoc Hum Genet. 2013;Chapter 17:Unit17.13. doi: 10.1002/0471142905.hg1713s77.
9
Podocyturia in paediatric patients with Fabry disease.法布里病患儿的足细胞尿
Nefrologia (Engl Ed). 2019 Mar-Apr;39(2):177-183. doi: 10.1016/j.nefro.2018.05.009. Epub 2018 Aug 20.
10
Absence of α-galactosidase cross-correction in Fabry heterozygote cultured skin fibroblasts.法布里病杂合子培养的皮肤成纤维细胞中缺乏α-半乳糖苷酶交叉校正。
Mol Genet Metab. 2015 Feb;114(2):268-73. doi: 10.1016/j.ymgme.2014.11.005. Epub 2014 Nov 12.

引用本文的文献

1
Expert review in diagnostic, therapeutic and follow-up of Fabry disease in Latin America based on patient care standards.基于患者护理标准的拉丁美洲法布里病诊断、治疗及随访专家评审
Mol Genet Metab Rep. 2025 Apr 16;43:101218. doi: 10.1016/j.ymgmr.2025.101218. eCollection 2025 Jun.
2
Baseline Characteristics of Fabry Disease "Amenable" Migalastat Patients in Argentinian Cohort.阿根廷队列法布里病“可用药”美拉他汀患者的基线特征。
Glob Health Epidemiol Genom. 2024 Feb 19;2024:9293896. doi: 10.1155/2024/9293896. eCollection 2024.
3
Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?法布里病:从酶替代疗法转换为口服伴侣分子米加司他:我们如今了解多少?
Healthcare (Basel). 2023 Feb 4;11(4):449. doi: 10.3390/healthcare11040449.
4
Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease.法布里病患儿的临床特征、肾脏受累情况及治疗选择
Front Pediatr. 2022 Jun 1;10:908657. doi: 10.3389/fped.2022.908657. eCollection 2022.

本文引用的文献

1
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.携带 α-半乳糖苷酶 A 突变的女性中早期心脏受累影响左心室纵向功能:混合正电子发射断层扫描和磁共振成像及斑点追踪超声心动图的作用。
Circ Cardiovasc Imaging. 2018 Apr;11(4):e007019. doi: 10.1161/CIRCIMAGING.117.007019.
2
Fabry disease revisited: Management and treatment recommendations for adult patients.重新审视法布里病:成年患者的管理和治疗建议。
Mol Genet Metab. 2018 Apr;123(4):416-427. doi: 10.1016/j.ymgme.2018.02.014. Epub 2018 Feb 28.
3
Prevalence of chronic kidney disease in fabry disease patients: Multicenter cross sectional study in Argentina.法布里病患者慢性肾脏病的患病率:阿根廷的多中心横断面研究
Mol Genet Metab Rep. 2017 May 23;12:41-43. doi: 10.1016/j.ymgmr.2017.05.007. eCollection 2017 Sep.
4
X-chromosome inactivation in female patients with Fabry disease.法布里病女性患者的X染色体失活
Clin Genet. 2016 Jan;89(1):44-54. doi: 10.1111/cge.12613. Epub 2015 Jun 22.
5
The kidney in Fabry's disease.法布里病的肾脏。
Clin Genet. 2014 Oct;86(4):301-9. doi: 10.1111/cge.12386. Epub 2014 May 30.
6
Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.慢性肾脏病的评估与管理:肾脏病:改善全球预后 2012 临床实践指南概要。
Ann Intern Med. 2013 Jun 4;158(11):825-30. doi: 10.7326/0003-4819-158-11-201306040-00007.
7
Interdisciplinary approach towards female patients with Fabry disease.对法布里病女性患者的跨学科治疗方法。
Eur J Clin Invest. 2012 Apr;42(4):455-62. doi: 10.1111/j.1365-2362.2011.02614.x. Epub 2011 Nov 3.
8
Fabry disease.法布里病。
Orphanet J Rare Dis. 2010 Nov 22;5:30. doi: 10.1186/1750-1172-5-30.
9
Globotriaosylceramide leads to K(Ca)3.1 channel dysfunction: a new insight into endothelial dysfunction in Fabry disease.神经节苷脂 GM1 导致 K(Ca)3.1 通道功能障碍:法布里病内皮功能障碍的新认识。
Cardiovasc Res. 2011 Feb 1;89(2):290-9. doi: 10.1093/cvr/cvq333. Epub 2010 Oct 21.
10
Prognostic indicators of renal disease progression in adults with Fabry disease: natural history data from the Fabry Registry.法布瑞病成人肾脏疾病进展的预后指标:来自法布瑞登记处的自然病史数据。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2220-8. doi: 10.2215/CJN.04340510. Epub 2010 Sep 2.